NCT01573182View on ClinicalTrials.gov

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 3, 2018

Study Completion Date

May 3, 2018

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

Zostavax

VZV seropositive donors 50 years and over will receive vaccination with a live attenuated herpes zoster vaccine (Zostavax) by the IM route 4 to 6 weeks prior to stem cell harvesting.

Trial Locations (1)

2145

Westmead Hospital, Sydney

All Listed Sponsors
lead

University of Sydney

OTHER

NCT01573182 - Herpes Zoster Vaccine for Bone Marrow Transplant Donors | Biotech Hunter | Biotech Hunter